Antitumor Activity of Intratumoral Ethanol Injection in an Orthotopic Pancreatic Cancer Cell Mouse Xenograft Model

Abstract

Purpose Pancreatic cancer is a lethal disease and usually is diagnosed at advanced stages of disease. This study assessed the effects of intratumoral ethanol injection using an endoscopic ultrasound (EUS) probe on the control of pancreatic cancer in a mouse orthotopic xenograft model. Materials and Methods The subcutaneous and orthotopic human pancreatic cancer cell mouse xenograft models were established. Different concentrations of ethanol (0–95%) were injected into subcutaneous xenograft tumors. In the orthotopic tumor model, ethanol was injected into the tumor lesions under the guidance of a high-frequency EUS probe. Tumor volume, relative tumor volume (RTV), and histopathology were evaluated. The serum amylase level was analyzed at baseline and 24 h after treatment in the orthotopic tumor model. Results Injection of 40–95% ethanol induced tumor necrosis in the subcutaneous tumor model, while there was no statistical difference between the RTVs of the two groups (P = 0.81). In the orthotopic tumor model, the RTV of the 80% ethanol treatment group was less than that of the saline injection group (P < 0.01); and histologically, there was a large area of necrosis observed in the 80% ethanol group. The serum amylase level was slightly elevated at 24 h after injection and returned to the baseline level at 7 days. Conclusion Injection of 80% ethanol into xenograft tumor lesions of orthotopic pancreatic cancer resulted in tumor necrosis, and the procedure was safe and effective. Future studies will further confirm its antitumor activity as well as assess its safety and feasibility.

Reproducibility of academic preclinical translational research: lessons from the development of Hedgehog pathway inhibitors to treat cancer

“…One concern is that, as the lesions spread due to daily treatment, this may ultimately have led to inoculation of the drug near or even directly into the tumour mass, potentially inhibiting tumour cell growth, not because of suppression of the HH pathway, but as a result of the off-target toxic effects of the high drug concentrations. In a number of cases, alcohol was present in the carrier at a level of 20%, which causes necrosis at the site of inoculation into the tumours [ 33 ]. Recognizing this problem, alternative carriers lacking ethanol were developed for cyclopamine.…”

Identification of Energy Metabolism-Related Gene Signatures From scRNA-Seq Data to Predict the Prognosis of Liver Cancer Patients

“…ENO1 encodes α-enolase, which is one of the three enolase isozymes found in mammals ( Zhang et al, 2020 ). ENO1 is overexpressed in a variety of GI tumors, including colon, pancreatic, and gastric cancers ( Hang et al, 2018 ), and promotes tumor development ( Cheng et al, 2019 ; Xu et al, 2019 ). In addition, ENO1 is highly expressed in liver cancer, promotes glucose uptake and lactate production by tumor cells, and is involved in tumor cell division, proliferation, apoptosis, metastasis, immunomodulation, and chemoresistance ( Qiao et al, 2018 ; Jiang et al, 2020 ).…”

Innovative Experimental Ultrasound and US-Related Techniques Using the Murine Model in Pancreatic Ductal Adenocarcinoma: A Systematic Review

“…Other studies have assessed the therapeutic efficacy of endoscopic ultrasound (EUS)guided injection of ethanol versus 3-bromopyruvate to treat the orthotopic xenograft murine model of pancreatic cancer obtaining tumour necrosis, and the procedure was safe and effective [103,104].…”